A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
Trained in microbiology, Slaughter championed science, women’s health, and consumer protections as a member of the US House of Representatives.
A device dubbed the “mother machine” enables real-time observation of mutagenesis in single bacterial cells.
The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.
Analysis of DNA samples from more than 520,000 people brings the number of known stroke-risk loci to 32.
The biologist earned a Nobel Prize in 2002 for his work on C. elegans.
Biodegradable pigments could be custom-grown by bacteria in the future, say researchers.
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
A whole-genome analysis of people who experience color when they listen to sounds points to a handful of genes involved in neural development.
The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
The US Senate narrowly approved the politician, who does not have a science background.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
© 1986-2018 The Scientist
